Somatostatin Receptor targeted radioligand therapy in head and neck paraganglioma

被引:0
|
作者
Roll, W. [1 ]
Muether, M. [2 ]
Zinnhardt, B. [1 ]
Stegger, L. [1 ]
Weckesser, M. [1 ]
Schaefers, M. [1 ]
Stummer, W. [2 ]
Rahbar, K. [1 ]
机构
[1] Univ Hosp Munster, Dept Nucl Med, Munster, Germany
[2] Univ Hosp Munster, Dept Neurosurg, Munster, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0558
引用
收藏
页码:S637 / S637
页数:1
相关论文
共 50 条
  • [31] Paraganglioma of the hypoglossal nerve - A rare location of head and neck paraganglioma
    Ntomouchtsis, A.
    Kinigou, M.
    Tsova, S.
    Megalopoulos, A.
    Antoniades, K.
    ORAL ONCOLOGY, 2009, : 125 - 125
  • [32] FGFR-targeted therapy in head and neck carcinomas
    Dietrich, Dimo
    HNO, 2021, 69 (03) : 172 - 184
  • [33] Current aspects of targeted therapy in head and neck tumors
    Dietz, Andreas
    Boehm, Andreas
    Mozet, Christian
    Wichmann, Gunnar
    Giannis, Athanassios
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2008, 265 (Suppl 1) : S3 - S12
  • [34] Current aspects of targeted therapy in head and neck tumors
    Andreas Dietz
    Andreas Boehm
    Christian Mozet
    Gunnar Wichmann
    Athanassios Giannis
    European Archives of Oto-Rhino-Laryngology, 2008, 265 : 3 - 12
  • [35] Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck
    Duet, M
    Sauvaget, E
    Pételle, B
    Rizzo, N
    Guichard, JP
    Wassef, M
    Le Cloirec, J
    Herman, P
    Huy, PTB
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (11) : 1767 - 1774
  • [36] The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy
    Pomerantz, RG
    Grandis, JR
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 734 - 743
  • [37] Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer
    Cripps, C.
    Winquist, E.
    Devries, M. C.
    Stys-Norman, D.
    Gilbert, R.
    CURRENT ONCOLOGY, 2010, 17 (03) : 37 - 48
  • [38] Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies
    Jonathan Moreira
    Alexander Tobias
    Michael P. O’Brien
    Mark Agulnik
    Drugs, 2017, 77 : 843 - 857
  • [39] Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies
    Moreira, Jonathan
    Tobias, Alexander
    O'Brien, Michael P.
    Agulnik, Mark
    DRUGS, 2017, 77 (08) : 843 - 857
  • [40] Somatostatin Antagonists for Radioligand Therapy of Nonendocrine Tumors
    Hindie, Elif
    Zanotti-Fregonara, Paolo
    Morgat, Clement
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 544 - 544